Atomo Diagnostics Limited (ASX:AT1)

Australia flag Australia · Delayed Price · Currency is AUD
0.0200
+0.0040 (25.00%)
Jul 16, 2025, 4:10 PM AEST
-20.00%
Market Cap15.42M
Revenue (ttm)4.22M
Net Income (ttm)-6.45M
Shares Out770.84M
EPS (ttm)-0.01
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume19,376,056
Average Volume1,710,258
Open0.0160
Previous Close0.0160
Day's Range0.0160 - 0.0250
52-Week Range0.0140 - 0.0270
Beta0.95
RSI78.25
Earnings DateJul 31, 2025

About Atomo Diagnostics

Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. The company offers rapid diagnostic test devices for HIV screening, pregnancy test, and respiratory test. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia. [Read more]

Sector Healthcare
Founded 2010
Employees 85
Stock Exchange Australian Securities Exchange
Ticker Symbol AT1
Full Company Profile

Financial Performance

In 2024, Atomo Diagnostics's revenue was 4.09 million, an increase of 60.65% compared to the previous year's 2.54 million. Losses were -6.85 million, -31.23% less than in 2023.

Financial Statements

News

There is no news available yet.